Product Information
ERYTHROMYCIN 250 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.7409 per EA under NDC 70710104703. Its NADAC has been published 146 times since Sep 13, 2023.
Strength
250 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710104703
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA212693On Market Since
6/30/2023
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 250 MG TABLET has been published 146 times since Sep 13, 2023, and over the history we have for it it has declined 64.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7409 per EA |
|---|---|
| All-time high | $6.9444 (Oct 11, 2023) |
| All-time low | $1.3349 (May 22, 2024) |
| 52-week high | $1.8691 |
| 52-week low | $1.3571 |
| Median price | $1.8320 |
| Average price | $2.2191 |
| Largest weekly change | -54.7% (Apr 17, 2024) |
| Weeks tracked | 146 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 250 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.7409 per EA (NDC 70710104703), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 250 MG TABLET has declined 64.6%. It has been tracked across 146 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 250 MG TABLET?
Since Sep 13, 2023, the NADAC for ERYTHROMYCIN 250 MG TABLET has ranged from a low of $1.3349 (May 22, 2024) to a high of $6.9444 (Oct 11, 2023), with a median of $1.8320 per EA.
Are there cheaper alternatives to ERYTHROMYCIN 250 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ERYTHROMYCIN 250 MG TABLET, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 250 MG TABLET?
ERYTHROMYCIN 250 MG TABLET (NDC 70710104703) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification